ALX Oncology stockholders elect directors, approve advisory pay vote, ratify KPMG

ALX ONCOLOGY HOLDINGS INC

Scott Garland (23.6M for) and Barbara Klencke (30.8M for) elected as Class II directors to serve until 2028 annual meeting.
Advisory vote on named executive officer compensation approved: 22.1M for, 8.7M against, 1.4M abstain.
KPMG LLP ratified as independent auditor for fiscal year 2025: 41.8M for, 0.06M against, 2.2M abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.